Literature DB >> 32239278

Reply to ocular manifestation, eye protection, and COVID-19.

Tracy H T Lai1,2, Emily W H Tang1,2, Sandy K Y Chau3, Kenneth K W Li4,5.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32239278      PMCID: PMC7111588          DOI: 10.1007/s00417-020-04663-2

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


× No keyword cloud information.
Dear Editor, We would like to thank Dr. Mungmungpuntipantip for his comments to our article [1]. We would like to reiterate the importance of eye protection for ophthalmologists. As stated in our article, ophthalmologists are in close proximity with patients during both slit lamp examination and direct ophthalmoscopy [2]. Protective eyewear can prevent direct inoculation of respiratory droplets through the conjunctiva. Secondly, protective eyewear can act as a barrier to prevent ophthalmologists from inoculating the virus directly into their own conjunctiva, through inadvertent eye rubbing with a contaminated hand. Thirdly, conjunctivitis, though rare, could be the first presentation of COVID-19 [3], and the SARS-CoV-2 virus has been isolated in tears of COVID-19 patients [4]. Ophthalmologists may be caught off-guard if these conjunctivitis patients without any respiratory symptoms present to the eye clinic. Proper protection with face masks and eyewear would help to lower the risk of transmission.
  4 in total

1.  2019-nCoV transmission through the ocular surface must not be ignored.

Authors:  Cheng-Wei Lu; Xiu-Fen Liu; Zhi-Fang Jia
Journal:  Lancet       Date:  2020-02-06       Impact factor: 79.321

2.  Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection.

Authors:  Jianhua Xia; Jianping Tong; Mengyun Liu; Ye Shen; Dongyu Guo
Journal:  J Med Virol       Date:  2020-03-12       Impact factor: 2.327

3.  Ocular manifestation, eye protection, and COVID-19.

Authors:  Rujittika Mungmungpuntipantip; Viroj Wiwanitkit
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-03-30       Impact factor: 3.117

4.  Stepping up infection control measures in ophthalmology during the novel coronavirus outbreak: an experience from Hong Kong.

Authors:  Tracy H T Lai; Emily W H Tang; Sandy K Y Chau; Kitty S C Fung; Kenneth K W Li
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-03-03       Impact factor: 3.535

  4 in total
  2 in total

Review 1.  Multidisciplinary Approach to the Diagnosis and In-Hospital Management of COVID-19 Infection: A Narrative Review.

Authors:  Giuliano Lo Bianco; Santi Di Pietro; Emilia Mazzuca; Aurelio Imburgia; Luca Tarantino; Giuseppe Accurso; Vincenzo Benenati; Federica Vernuccio; Claudio Bucolo; Salvatore Salomone; Marianna Riolo
Journal:  Front Pharmacol       Date:  2020-12-09       Impact factor: 5.810

2.  Mitigating the transmission of infection and death due to SARS-CoV-2 through non-pharmaceutical interventions and repurposing drugs.

Authors:  Chittaranjan Mondal; Debadatta Adak; Abhijit Majumder; Nandadulal Bairagi
Journal:  ISA Trans       Date:  2020-09-28       Impact factor: 5.911

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.